Slaughter and May advises ELIQUENT Life Sciences and GHO Capital Partners LLP on the acquisition of RApport Global Strategic Services

Slaughter and May advised ELIQUENT Life Sciences (“ELIQUENT”) (formerly Validant) and GHO Capital Partners LLP (“GHO”) on ELIQUENT’s acquisition of RApport Global Strategic Services, a UK-based international regulatory consultancy supporting life science innovators and providing regulatory support to the pharmaceutical, biotechnological and medical device industries.

ELIQUENT is a global regulatory consulting firm for the life sciences industry whose growth strategy is supported by GHO, a leading specialist healthcare investment advisor based in London which has partnered with ELIQUENT since December 2018.